ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

Some supplements may help to lower your blood sugar, with Pick recommending berberine, myo-inositol, alpha-lipoic acid, ...

The Montana School for the Deaf and the Blind (MSDB) is celebrating a significant upgrade on campus with the grand reopening ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

Participants in the SURPASS programme achieved average A1C reductions between 1.8% and 2.1% for Mounjaro 5 mg and between 1.7 ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity. Approved by the ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.